False-positive screening results in the European randomized study of screening for prostate cancer
- 31 December 2011
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 47 (18) , 2698-2705
- https://doi.org/10.1016/j.ejca.2011.06.055
Abstract
No abstract availableKeywords
Funding Information
- Beckman-Coulter-Hybritech Inc
This publication has 30 references indexed in Scilit:
- False-positive screening results in the Finnish prostate cancer screening trialBritish Journal of Cancer, 2010
- Cumulative Incidence of False-Positive Results in Repeated, Multimodal Cancer ScreeningAnnals of Family Medicine, 2009
- Screening and Prostate-Cancer Mortality in a Randomized European StudyNew England Journal of Medicine, 2009
- Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and ContextJNCI Journal of the National Cancer Institute, 2009
- Interval Cancers in Prostate Cancer Screening: Comparing 2- and 4-Year Screening Intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and RotterdamJNCI Journal of the National Cancer Institute, 2007
- Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trialBritish Journal of Cancer, 2007
- Second Round Results of the Finnish Population-Based Prostate Cancer Screening TrialClinical Cancer Research, 2004
- ERSPC: features and preliminary results from the Antwerp study centre.BJU International, 2003
- Specific features of the Italian section of the ERSPC.BJU International, 2003
- Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence TrendsJNCI Journal of the National Cancer Institute, 2002